ReviewFrontiers in immunology2021

The Use of Biologic Modifiers as a Bridge to Hematopoietic Cell Transplantation in Primary Immune Regulatory Disorders.

Danielle E Arnold et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.